SCHEMBL24834657

SCHEMBL24834657

Cc1cccc(Nc2nccc3c(N)c(C)ccc23)c1F

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.45
BRAF P15056 3/20 0.44
RAF1 P04049 2/20 0.44
CSF1R P07333 1/20 0.44
ARAF P10398 1/20 0.44
DDR1 Q08345 1/20 0.44
DDR2 Q16832 1/20 0.44
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
IDO1 P14902 1/20 0.35
LRRK2 Q5S007 1/20 0.34
TP53 P04637 1/20 0.34
RET P07949 1/20 0.33
KIF5B P33176 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24399558 0.89 RAF1 (0.54) EGFRBRAFRAF1CSF1RARAF
SCHEMBL30162852 0.89 RAF1 (0.54) EGFRBRAFRAF1CSF1RARAF
SCHEMBL24835283 0.87 EGFR (0.39) EGFRBRAFRAF1CSF1RARAF
SCHEMBL25371810 0.86 EGFR (0.46) EGFRBRAFRAF1CSF1RARAF
SCHEMBL30400384 0.86 EGFR (0.46) EGFRBRAFRAF1CSF1RARAF
SCHEMBL26207960 0.85 LRRK2 (0.48) EGFRBRAFRAF1CSF1RARAF
SCHEMBL24399760 0.83 BRAF (0.45) EGFRBRAFRAF1CSF1RARAF
SCHEMBL24834723 0.81 EGFR (0.41) EGFRBRAFRAF1CSF1RARAF
SCHEMBL29638582 0.81 BRAF (0.35) EGFRBRAFRAF1CSF1RARAF
SCHEMBL26210990 0.81 BRAF (0.35) EGFRBRAFRAF1CSF1RARAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278981-A1 SYNTHESIS OF A BIS-MESYLATE SALT OF 4-AMINO-N-(1 -((3-CHLORO-2- FLUOROPHENYL)AMINO)-6-METHYLISOQUINOLIN-5-YL)THIENO[3,2- D]PYRIMIDINE-7-CARBOXAMIDE AND INTERMEDIATES THERETO GENENTECH, INC. (US) 2023-01-05 WO disclosed